Bioanalysis Zone is part of Taylor & Francis Group.
Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.
Follow us on social media
Sign up for our Bioanalysis Zone weekly news round-up
Interference from anti-drug antibodies on the quantification of insulin: a comparison of...
Patient-centric microsampling for abrocitinib pharmacokinetics: multiple-analytes assay bridging using Tasso device
Assessing prognosis by quantifying FcγRIIa on fixed platelets
Can capillary microsampling facilitate a clinical pharmacokinetics study of cefazolin in critically...
Critical reagent considerations for immunogenicity assay development for bispecific biotherapeutic candidates
Mitigating target interference challenges in bridging immunogenicity assay to detect anti-tocilizumab antibodies
Solving selectivity issues in LBAs: case study using Gyrolab to quantify CB307,...
Qualification of a 21-valent pneumococcal urine antigen detection assay and development of...
2023 White Paper on recent issues in bioanalysis: deuterated drugs; LNP; tumor/FFPE...
